Skip to main content
CCAPCrescent Capital BDC, Inc.Sell5.9·$11.05+0.09%
SellModerate Confidence
Investment thesis

Crescent Capital BDC screens cheap with notable insider buying support, but declining revenue, downward-trending estimates, and a confirmed technical downtrend argue for a cautious, reduced position despite the early signs of recovery.

Thesis pillars

  • Cheap Valuation Low PegStable
  • Notable Insider Buying ConvictionStable
  • Confirmed Technical DowntrendStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Crescent Capital BDC, Inc. (CCAP) Stock Analysis

Recovery setup · Inst Constrain edge

SellVALUE-TRAP 1/5ValueGrowthShortModerate Confidence

Financial Services · Asset Management

Sell if holding. Multiple concerning factors at $11.05: Leverage penalty (D/E 1.3): -0.5; Below 200-MA, MA slope -3.0%/30d (confirmed downtrend).

Crescent Capital BDC, Inc. is a business development company that originates first-lien, unitranche, second-lien, and unsecured debt investments in U.S. middle-market companies with $10 million to $250 million of EBITDA. The company is externally managed by Crescent Cap... Read more

$11.05+10.2% A.UpsideScore 5.9/10#74 of 244 Asset Management
QualityF-score7 / 9FCF yield7.07%
IncomeYield14.38%(5y avg 9.95%)Payout420.00%at-risk
Stop $10.61Target $12.18(analyst − 13%)A.R:R 2.0:1
Analyst target$14.00+26.7%7 analysts
$12.18our TP
$11.05price
$14.00mean
$16

Sell if holding. Multiple concerning factors at $11.05: Leverage penalty (D/E 1.3): -0.5; Below 200-MA, MA slope -3.0%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 51. Score 5.9/10, moderate confidence.

Passes 8/10 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 36d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Aug 12, 202636d to earnings· next earnings call

Thesis

Rewards
Attractive valuation
Positive insider activity
Risks
Leverage penalty (D/E 1.3): -0.5
Below 200-MA, MA slope -3.0%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)27.5
P/E (Fwd)7.4
Mkt Cap$405M
EV/EBITDA
Profit Mgn9.3%
ROE2.2%
Rev Growth-10.0%
Beta0.58
Dividend14.38%
Rating analysts14

Quality Signals

Piotroski F7/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
1.6
Growth Rank
1.8
Value Rank
5.4

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
2.2
Support Resistance
3.1
52w Position
5.6
GatesMomentum 5.5<5.5 (soft — BUY_NOW allowed but watch)Death cross (50MA < 200MA)Momentum 5.5>=4.5A.R:R 2.0 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 36d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
51 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $10.60Resistance $11.25

Price Targets

$11
$12
A.Upside+10.2%
A.R:R2.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Analyst Consensus

Analysts14
Consensus4.0/5
Avg Target$14

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-12 (36d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CCAP stock a buy right now?

Sell if holding. Multiple concerning factors at $11.05: Leverage penalty (D/E 1.3): -0.5; Below 200-MA, MA slope -3.0%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 51. Prior stop was $10.61. Score 5.9/10, moderate confidence.

What is the CCAP stock price target?

Take-profit target: $12.18 (+10.2% upside). Prior stop was $10.61. Stop-loss: $10.61.

What are the risks of investing in CCAP?

Leverage penalty (D/E 1.3): -0.5; Below 200-MA, MA slope -3.0%/30d (confirmed downtrend).

Is CCAP overvalued or undervalued?

Crescent Capital BDC, Inc. trades at a P/E of 27.5 (forward 7.4). TrendMatrix value score: 7.8/10. Verdict: Sell.

What do analysts say about CCAP?

14 analysts cover CCAP with a consensus score of 4.0/5. Average price target: $14.

What does Crescent Capital BDC, Inc. do?Crescent Capital BDC, Inc. is a business development company that originates first-lien, unitranche, second-lien, and...

Crescent Capital BDC, Inc. is a business development company that originates first-lien, unitranche, second-lien, and unsecured debt investments in U.S. middle-market companies with $10 million to $250 million of EBITDA. The company is externally managed by Crescent Cap Advisors, an affiliate of Crescent, a roughly $50 billion credit investment manager, and earns interest income, dividend income, and capital gains from its portfolio while paying the Adviser a 1.25% base management fee plus incentive fees.

Related stocks: ETO (Eaton Vance Tax-Advantage Globa) · WIW (Western Asset Inflation-Linked ) · PAX (Patria Investments Limited) · TWN (Taiwan Fund, Inc. (The)) · VINP (Vinci Compass Investments Ltd.)
Home Stocks CCAP

Latest news

No recent news